ORBIMED ADVISORS LLC Insider Trading $ADAP Adaptimmune Therapeutics PLC
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in GLAUKOS Corp ($GKOS) and Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and in ACCELERON PHARMA INC ($XLRN) and Director in ProNAi Therapeutics Inc ($DNAI) and 10% Owner in AVEDRO INC ($AVDR) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in SI-BONE, Inc. ($SIBN) and Director in Xtant Medical Holdings, Inc. ($XTNT) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and Director in Otonomy, Inc. ($OTIC) and 10% Owner in Arsanis, Inc. ($ASNS) and 10% Owner in Principia Biopharma Inc. ($PRNB) and Director in Acutus Medical, Inc. ($AFIB) and Director in SYNLOGIC, INC. ($MIRN) and 10% Owner in NeuroPace Inc ($NPCE) and 10% Owner in GRAYBUG VISION, INC. ($GRAY) and 10% Owner in Sientra, Inc. ($SIEN) and 10% Owner in TELA Bio, Inc. ($TELA) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Dimension Therapeutics, Inc. ($DMTX) and 10% Owner in Guardant Health, Inc. ($GH) and 10% Owner in ViewRay, Inc. ($VRAY) and Director in ViewRay, Inc. ($VRAY) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and 10% Owner in Inspire Medical Systems, Inc. ($INSP) and Director in Inspire Medical Systems, Inc. ($INSP) and Director in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and Director in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Intellia Therapeutics, Inc. ($NTLA) and 10% Owner in Alector, Inc. ($ALEC) and Director in Alector, Inc. ($ALEC) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in NextCure, Inc. ($NXTC) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in IMARA Inc. ($IMRA) and Director in Keros Therapeutics, Inc. ($KROS) and Director in Prelude Therapeutics Inc ($PRLD) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in resTORbio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and Director in Edgewise Therapeutics, Inc. ($EWTX) and Director in 89bio, Inc. ($ETNB) and Director in Arcutis Biotherapeutics, Inc. ($ARQT) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Fusion Pharmaceuticals Inc. ($FUSN) and Director in Terns Pharmaceuticals, Inc. ($TERN) and Director in Ikena Oncology, Inc. ($IKNA).
ORBIMED ADVISORS LLC in Adaptimmune Therapeutics PLC
Trading Symbol: ADAPIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 4,902,910 shares
Current Value: $22,210,182
Latest Transaction: Jun 06 2018
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in Adaptimmune Therapeutics PLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETNB, XLRN, AFIB, ADAP, TORC, AGLE, ARPO, ALEC, ALPN, ARQT, ARMO, BOLD, AVDR, CNST, CRVS, CTIC, DBTX, DMTX, EWTX, FUSN, GKOS, GRAY, GH, IKNA, IMRA, INSP, NTLA, ICPT, KALA, KROS, KNTE, LOGC, LOXO, NPCE, NXTC, ORIC, OTIC, PIRS, PMVP, PRLD, PRVL, PRNB, RLYP, RPTX, RPBIF, RYTM, SCPH, SELB, SIBN, SIEN, SRRA, SBTX, ROKA, SWTX, STDY, SYBX, THOR, TELA, TERN, TCDA, TPTX, VRAY, ASNS, XTNT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 06 2018 | ADAP | Adaptimmune Therap ... | ORBIMED ADVISORS LLC | Director | Sell | S | 13.49 | 1,600 | 21,584 | 4,901,310 | 4.9 M to 4.9 M (-0.03 %) |
Jun 06 2018 | ADAP | Adaptimmune Therap ... | ORBIMED ADVISORS LLC | Director | Sell | S | 13.57 | 17,100 | 232,047 | 4,902,910 | 4.9 M to 4.9 M (-0.35 %) |
Jun 01 2018 | ADAP | Adaptimmune Therap ... | ORBIMED ADVISORS LLC | Director | Sell | S | 13.49 | 50,000 | 674,500 | 4,920,010 | 5 M to 4.9 M (-1.01 %) |
Jun 01 2018 | ADAP | Adaptimmune Therap ... | ORBIMED ADVISORS LLC | Director | Sell | S | 13.52 | 121,000 | 1,635,920 | 4,970,010 | 5.1 M to 5 M (-2.38 %) |
May 16 2018 | ADAP | Adaptimmune Therap ... | ORBIMED ADVISORS LLC | Director | Sell | S | 13.50 | 10,300 | 139,050 | 5,091,010 | 5.1 M to 5.1 M (-0.20 %) |
Mar 29 2018 | ADAP | Adaptimmune Therap ... | ORBIMED ADVISORS LLC | Director | Sell | S | 11.53 | 31,983 | 368,764 | 5,101,310 | 5.1 M to 5.1 M (-0.62 %) |
Mar 29 2018 | ADAP | Adaptimmune Therap ... | ORBIMED ADVISORS LLC | Director | Sell | S | 11.50 | 1,016,084 | 11,684,966 | 5,133,293 | 6.1 M to 5.1 M (-16.52 %) |
Mar 28 2017 | ADAP | Adaptimmune Therap ... | ORBIMED ADVISORS LLC | Director | Buy | P | 4.20 | 1,190,476 | 4,999,999 | 6,149,377 | 5 M to 6.1 M (+24.01 %) |
May 25 2016 | ADAP | Adaptimmune Therap ... | ORBIMED ADVISORS LLC | Director | Buy | P | 10.48 | 518,400 | 5,432,832 | 29,753,404 | 29.2 M to 29.8 M (+1.77 %) |
May 25 2016 | ADAP | Adaptimmune Therap ... | ORBIMED ADVISORS LLC | Director | Buy | P | 10.40 | 1,191,600 | 12,392,640 | 29,235,004 | 28 M to 29.2 M (+4.25 %) |
May 25 2016 | ADAP | Adaptimmune Therap ... | ORBIMED ADVISORS LLC | Director | Buy | P | 10.04 | 2,400 | 24,096 | 28,043,404 | 28 M to 28 M (+0.01 %) |
Page: 1